Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Accumulated Depreciation (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Accumulated Depreciation for 7 consecutive years, with $94.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation rose 30.54% to $94.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94.1 million through Dec 2025, up 30.54% year-over-year, with the annual reading at $94.1 million for FY2025, 30.54% up from the prior year.
  • Accumulated Depreciation for Q4 2025 was $94.1 million at Beam Therapeutics, up from $88.6 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $94.1 million in Q4 2025, with the low at $10.3 million in Q1 2021.
  • Average Accumulated Depreciation over 5 years is $45.9 million, with a median of $42.2 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation surged 94.78% in 2021, then soared 30.54% in 2025.
  • Over 5 years, Accumulated Depreciation stood at $16.1 million in 2021, then surged by 87.61% to $30.2 million in 2022, then soared by 66.33% to $50.2 million in 2023, then soared by 43.69% to $72.1 million in 2024, then soared by 30.54% to $94.1 million in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods came in at $94.1 million, $88.6 million, and $83.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.